Search

everythinglearnresearchcommunity

for

Search:↓

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Some vitamins, amino acids, and alternative medicines can cause serious side effects, including bone, muscle, and skin issues, and healthcare professionals should be aware of these risks.

Microneedling improves skin and hair conditions by enhancing treatment absorption and stimulating growth factors.

A woman with lupus and severe nerve damage improved with specific treatments.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.